Echo Therapeutics, Inc.

FY: Dec 31 2016

Q: Sep 30 2016

Q: Sep 30 2016

Q: Jun 30 2016

Q: Mar 31 2016

Q: Mar 31 2016

FY: Dec 31 2015

Q: Sep 30 2015

Q: Jun 30 2015

Q: Mar 31 2015

Q: Sep 30 2014

FY: Dec 31 2014

FY: Dec 31 2014

Q: Sep 30 2014

Q: Sep 30 2014

Q: Sep 30 2014

Q: Jun 30 2014

Q: Mar 31 2014

FY: Dec 31 2013

FY: Dec 31 2013

8.01

5.02

2.04

8.01,9.01

8.01,9.01

8.01

4.01,9.01

1.01,2.03,5.02,9.01

2.03,9.01

5.02

1.01,2.03,5.02,9.01

3.01

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Submission of Matters to a Vote of Security Holders

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

5.07

2.03,9.01

2.03,8.01,9.01

3.01

Notification of removal from listing and/or registration on a national securities exchange

Notice of Effectiveness

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

06b

06b

Withdrawal of a registration statement

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

No description available

No description available

No description available

Additional proxy soliciting materials filed by a non-management party

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional proxy soliciting materials filed by a non-management party

No description available

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional proxy soliciting materials filed by a non-management party

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

SCHOENBART ALAN WAYNE

GOLDBERG MICHAEL M

GOLDBERG SHEPARD M

SCHOENBART ALAN WAYNE

SCHOENBART ALAN WAYNE

SCHOENBART ALAN WAYNE

GOLDBERG MICHAEL M

Edelman Elazer R

GOLDBERG SHEPARD M

SCHOENBART ALAN WAYNE

Hollander Scott Wayne

GOLDBERG SHEPARD M

GOLDBERG MICHAEL M

Edelman Elazer R

Edelman Elazer R

SCHOENBART ALAN WAYNE

Hollander Scott Wayne

Platinum-Montaur Life Sciences, LLC

GOLDBERG SHEPARD M

GOLDBERG MICHAEL M

No description available

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC